Okay, let's tackle this question about the iodine isotope used in treating thyroid carcinoma. First, I need to recall the different iodine isotopes and their uses. I remember that radioactive iodine is commonly used in thyroid treatments. The two main ones are iodine-131 and iodine-123.

Wait, iodine-131 is used for both diagnosis and treatment, right? It's beta and gamma emitter. The beta particles destroy the thyroid tissue, which is why it's used in hyperthyroidism and thyroid cancer. But wait, iodine-123 is mainly a gamma emitter, so it's more for imaging, like in thyroid scans. So the treatment would be 131I.

The question is asking for the treatment of thyroid carcinoma. So the answer should be iodine-131. Let me check the options again. The correct answer is C, which is iodine-131. The other options might include 123I, 125I, or others. Iodine-125 is used in brachytherapy for other cancers, like prostate. Iodine-127 is stable and not radioactive. So the treatment uses 131I because it's a beta emitter that can kill cancer cells. The gamma emissions also help in monitoring the treatment. So the core concept is understanding the different isotopes and their applications in thyroid disorders. The clinical pearl here is remembering that 131I is the treatment, while 123I is for imaging. That's a key point for exams.

**Core Concept**
The treatment of thyroid carcinoma relies on radioactive iodine isotopes that selectively accumulate in thyroid tissue due to the sodium-iodide symporter (NIS). Iodine-131 (¹³¹I) is the standard therapeutic isotope because it emits beta particles (which destroy thyroid tissue) and gamma rays (for diagnostic imaging and dosimetry).

**Why the Correct Answer is Right**
Iodine-131 (¹³¹I) is a beta-emitting radionuclide that is taken up by thyroid follicular cells, including thyroid cancer cells. The high-energy beta particles cause localized DNA damage, leading to cell death. Its gamma emissions allow imaging to confirm uptake and guide dosing. It is specifically used for ablating residual thyroid tissue post-surgery and treating metastatic differentiated thyroid cancer (e.g., papillary or follicular).

**Why Each Wrong Option is Incorrect**
**Option A:** Iodine-123 (¹²³I) is a gamma-emitter used for diagnostic imaging (e.g., thyroid scans) but lacks therapeutic beta radiation.
**Option B:** Iodine-125 (¹²⁵I) is used in brachytherapy (e.g., for prostate cancer) and some research applications but has low-energy emissions unsuitable for thyroid ablation.
**Option D:** Stable iodine-127 (¹²⁷I) is non-radioactive and has no role in treatment.

**Clinical Pearl / High-Yield Fact**
Never confuse ¹³¹I (therapy) with ¹²³I (imaging). Remember: "1-3-1" (¹³¹) for **Treatment**,

✓ Correct Answer: A. Iodine 131